ClinicalTrials.Veeva

Menu

Case-control Study of Sleep Disorders in Children With Cystic Fibrosis

U

University Hospital, Strasbourg, France

Status

Completed

Conditions

Sleep Disorder
Cystic Fibrosis

Treatments

Behavioral: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Our primary purpose is to compare the prevalence of sleep disorders in children aged 6 to 17 with cystic fibrosis versus controls with a Sleep disorder screening score, the SDSC. Our hypothesis is that patients aged 6 to 17 with cystic fibrosis have a higher prevalence of sleep disturbances than the general population of the same age group.

Our secondary hypothesis is that these sleep disorders are mixed and that there are non-respiratory causes, sometimes modifiable by simple non-medical treatment and that's why our secondary purpose is to identify the responsible factors, in particular non-respiratory factors in the 2 groups and to compare them.

Enrollment

150 patients

Sex

All

Ages

6 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria for the case group :

  • Cystic fibrosis followed at the pediatric (Centre de Ressources et de Compétences de la Mucoviscidose) in Strasbourg
  • Aged from 6 to 17 years old
  • Non hospitalized
  • Able to read and understand French language
  • Accompanied by at least one of his parents

Inclusion criteria for the control group :

  • Emergency surgical consultation
  • Aged from 6 to 17 years old
  • Non hospitalized
  • Able to read and understand French langage
  • Accompanied by at least one of his parents

Exclusion criteria:

  • Children under 6 years old
  • Children over 17 years old
  • Children and parents who don't understand or can't read French language
  • Hospitalized children
  • Children unaccompanied by their parents

Trial design

150 participants in 2 patient groups

Cystic fibrosis, children from 6 to 17.
Description:
This group is made up of children with cystic fibrosis followed at the Strasbourg pediatrics CRCM, aged from 6 to 17 years old, not hospitalized at the time of inclusion, without any other criterion prejudging the seriousness of the pathology.
Treatment:
Behavioral: Questionnaire
Control group, children from 6 to 17.
Description:
This group is the control group. It is made up of children consulting in pediatric surgical emergencies, aged 6 to 17 years. Surgical emergencies were chosen because it is a point of consultation, rather accidental, where sleep has often not been impacted in the previous months and where the frequency of chronic pathology is not higher than the general population. An other criteria is that these children are accompanied by at least one of their parents and that they can read and understand French well.
Treatment:
Behavioral: Questionnaire

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems